BioHealth News Archive
Pfizer Establishes New Program to Support Continued Biotechnology Innovation | Business | oleantimesherald.com
Pfizer Inc. (NYSE: PFE) today announced the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will invest up to $500 million in…
Read More
Global Deaths Due to Various Causes and COVID-19
Always good to see a new relational perspective. #perspective #thinking #reflection #designthinking #innovationculture {iframe}https://www.linkedin.com/posts/all4innovation_perspective-thinking-reflection-activity-6673194763405078528-Yo_4/{/iframe}
Read More
Altimmune Launches Clinical Trial for COVID-19 Vaccine for the Treatment of Patients with Early SARS-CoV-2 infection – Biobuzz Directory
GAITHERSBURG, MD, June 1, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the U.S. Food and Drug Administration…
Read More
COVID-19 Vaccine Progress from 14 BioHealth Capital Region Organizations – BioHealth Capital Region – BioBuzz
Editor’s Note: This post was originally published on April 7, 2020. As updates are discovered and advancements are announced regarding the work below, details…
Read More
NodThera Announces Close of $55 Million Series B Financing
Financing round led by Novo Ventures and includes new investors Cowen Healthcare Investments and Sanofi Ventures, as well as existing investors 5AM Ventures, F-Prime…
Read More
CEOs, Academics Step Out to Fill National Leadership Void – Maryland Matters
Amid a wrenching series of crises that have riven the nation, particularly over matters of race and law enforcement, corporate leaders throughout Maryland have…
Read More
VCs Cautious of “COVID-19 Contortionists” and Telemedicine “Gold Rush” · BioBuzz
COVID-19 is fundamentally changing how we live, how we do business, and how we approach and deliver our healthcare. In the past 14 weeks,…
Read More
U.S. gives AstraZeneca $1 billion for COVID-19 vaccine candidate – UPI.com
May 21 (UPI) -- European pharmaceutical company AstraZeneca said Thursday it has received more than $1 billion from the U.S. government to develop its…
Read More
SARS-CoV-2 Infection Mapped through Respiratory Tract
SARS-CoV-2 is known to infect cells of the respiratory tract. A deeper understanding of which cells support the infection, and to what extent, could…
Read More
Emergent BioSolutions will produce COVID-19 vaccines in Baltimore, Rockville under $628 million federal contract – Baltimore Sun
Emergent BioSolutions Inc. will help produce COVID-19 vaccines in Baltimore and Rockville under a federal contract. Gaithersburg-based Emergent said Tuesday it will manufacture vaccines…
Read More
Novavax Awarded Department of Defense Contract for COVID-19 Vaccine Nasdaq:NVAX
GAITHERSBURG, Md., June 04, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today…
Read More
AstraZeneca Approaches Gilead About Potential Merger
AstraZeneca Plc has made a preliminary approach to rival drugmaker Gilead Sciences Inc. about a potential merger, according to people familiar with the matter,…
Read More
AstraZeneca lays out plans to produce 2 billion doses of Covid-19 vaccine
The drug giant AstraZeneca said Thursday that it has found partners to manufacture and distribute 2 billion doses of the experimental Covid-19 vaccine created…
Read More
Creatv Announces Positive Results for the LifeTracDx Blood Test in the Detection of Early Stage Cancer in Multiple Solid Tumors | Business Wire
ROCKVILLE, Md.--(BUSINESS WIRE)--Creatv MicroTech, a privately-held biotechnology company has pioneered a blood test for the universal screening of early stage cancer. They will present…
Read More
IBBR Request for Proposals (RFP): GMP Biomanufacturing Facility Available – Rockville, Maryland, USA | News | wfmz.com
ROCKVILLE, Md., Feb. 11, 2020 /PRNewswire/ -- The Institute for Bioscience and Biotechnology Research (IBBR) is accepting proposals to lease a bio-manufacturing facility configured…
Read More